James E. Smeeding

1.0k total citations
22 papers, 821 citations indexed

About

James E. Smeeding is a scholar working on Economics and Econometrics, Surgery and General Health Professions. According to data from OpenAlex, James E. Smeeding has authored 22 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 4 papers in Surgery and 4 papers in General Health Professions. Recurrent topics in James E. Smeeding's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical Economics and Policy (4 papers) and Gastroesophageal reflux and treatments (3 papers). James E. Smeeding is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical Economics and Policy (4 papers) and Gastroesophageal reflux and treatments (3 papers). James E. Smeeding collaborates with scholars based in United States, United Kingdom and South Korea. James E. Smeeding's co-authors include Richard A. Brook, Nathan L. Kleinman, Arthur K. Melkonian, Rok Seon Choung, Nicholas J. Talley, Krithika Rajagopalan, Harold H. Gardner, Edward C. Mansley, Nancy Joseph‐Ridge and Joel W. Hay and has published in prestigious journals such as The American Journal of Gastroenterology, Clinical Gastroenterology and Hepatology and The Journal of Clinical Psychiatry.

In The Last Decade

James E. Smeeding

22 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James E. Smeeding United States	15	267	210	177	121	112	22	821
Lucie Opatrny Canada	14	158 0.6×	45 0.2×	50 0.3×	120 1.0×	34 0.3×	28	938
Chris Dudley United Kingdom	16	363 1.4×	215 1.0×	193 1.1×	10 0.1×	105 0.9×	29	1.3k
Shayan Shirazian United States	12	64 0.2×	257 1.2×	30 0.2×	97 0.8×	76 0.7×	26	740
Jennifer Talley United States	15	314 1.2×	51 0.2×	404 2.3×	16 0.1×	37 0.3×	29	908
Betina T. Blak United Kingdom	12	189 0.7×	62 0.3×	17 0.1×	65 0.5×	103 0.9×	24	1.1k
Eric Esrailian United States	25	543 2.0×	144 0.7×	449 2.5×	21 0.2×	53 0.5×	54	1.6k
Vladimir Bezlyak United Kingdom	17	165 0.6×	43 0.2×	60 0.3×	176 1.5×	25 0.2×	31	1.4k
Gerardo Machnicki United States	15	162 0.6×	54 0.3×	15 0.1×	18 0.1×	188 1.7×	42	790
G. Mingardi Italy	13	106 0.4×	327 1.6×	25 0.1×	16 0.1×	41 0.4×	20	744
Evi Nagler Belgium	14	337 1.3×	443 2.1×	13 0.1×	18 0.1×	84 0.8×	33	1.3k

Countries citing papers authored by James E. Smeeding

Since Specialization

Citations

This map shows the geographic impact of James E. Smeeding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Smeeding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Smeeding more than expected).

Fields of papers citing papers by James E. Smeeding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Smeeding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Smeeding. The network helps show where James E. Smeeding may publish in the future.

Co-authorship network of co-authors of James E. Smeeding

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Smeeding. A scholar is included among the top collaborators of James E. Smeeding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Smeeding. James E. Smeeding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smeeding, James E., Daniel C. Malone, Monica Ramchandani, et al.. (2019). Biosimilars: Considerations for Payers.. PubMed. 44(2). 54–63. 26 indexed citations

Brook, Richard A., Krithika Rajagopalan, & James E. Smeeding. (2018). Healthcare Costs and Absenteeism Among Caregivers of Adults with Partial-Onset Seizures: Analysis of Claims from an Employer Database.. PubMed. 11(8). 396–403. 5 indexed citations

Baran, Robert W., Jennifer C. Samp, David Walker, et al.. (2015). Costs and absence of HCV-infected employees by disease stage. Journal of Medical Economics. 18(9). 691–703. 15 indexed citations

Kleinman, Nathan L., Mary Cifaldi, James E. Smeeding, James W. Shaw, & Richard A. Brook. (2013). Annual Incremental Health Benefit Costs and Absenteeism Among Employees With and Without Rheumatoid Arthritis. Journal of Occupational and Environmental Medicine. 55(3). 240–244. 25 indexed citations

Brook, Richard A., Nathan L. Kleinman, Rok Seon Choung, James E. Smeeding, & Nicholas J. Talley. (2011). Excess Comorbidity Prevalence and Cost Associated with Functional Dyspepsia in an Employed Population. Digestive Diseases and Sciences. 57(1). 109–118. 25 indexed citations

Brook, Richard A., Anna Forsythe, James E. Smeeding, & N. Lawrence Edwards. (2010). Chronic gout: epidemiology, disease progression, treatment and disease burden. Current Medical Research and Opinion. 26(12). 2813–2821. 87 indexed citations

Brook, Richard A., Nathan L. Kleinman, Rok Seon Choung, et al.. (2010). Functional Dyspepsia Impacts Absenteeism and Direct and Indirect Costs. Clinical Gastroenterology and Hepatology. 8(6). 498–503. 149 indexed citations

Mansley, Edward C., Kristina Chen, Nilay D. Shah, et al.. (2009). Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective: The ISPOR Drug Cost Task Force Report—Part III. Value in Health. 13(1). 14–17. 24 indexed citations

Garrison, Louis P., Edward C. Mansley, Thomas A. Abbott, et al.. (2009). Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II. Value in Health. 13(1). 8–13. 118 indexed citations

10.

Kleinman, Nathan L., Richard A. Brook, Pankaj Patel, et al.. (2007). The Impact of Gout on Work Absence and Productivity. Value in Health. 10(4). 231–237. 96 indexed citations

11.

Smeeding, James E., et al.. (2007). Exploratory economic evaluation of patients with COPD on a combination product versus individual components (ipratropium bromide and albuterol). Advances in Therapy. 24(4). 757–771. 3 indexed citations

12.

Gardner, Harold H., et al.. (2006). The Economic Impact of Bipolar Disorder in an Employed Population From an Employer Perspective. The Journal of Clinical Psychiatry. 67(8). 1209–1218. 80 indexed citations

13.

Rajagopalan, Krithika, et al.. (2006). Costs of physical and mental comorbidities among employees: a comparison of those with and without bipolar disorder. Current Medical Research and Opinion. 22(3). 443–452. 15 indexed citations

14.

Brook, Richard A., et al.. (2006). Incurring Greater Health Care Costs. The Primary Care Companion For CNS Disorders. 8(1). 17–24. 15 indexed citations

15.

Brook, Richard A., Nathan L. Kleinman, Pankaj Patel, et al.. (2006). The economic burden of gout on an employed population. Current Medical Research and Opinion. 22(7). 1381–1389. 62 indexed citations

16.

Kleinman, Nathan L., et al.. (2005). Lost Time, Absence Costs, and Reduced Productivity Output for Employees With Bipolar Disorder. Journal of Occupational and Environmental Medicine. 47(11). 1117–1124. 37 indexed citations

17.

Marsh, Wallace, et al.. (2004). A Cost Minimization Comparison of Two Surfactants—Beractant and Poractant alfa—Based Upon Prospectively Designed, Comparative Clinical Trial Data. The Journal of Pediatric Pharmacology and Therapeutics. 9(2). 117–125. 12 indexed citations

18.

Crawley, Joseph A., Richard A. Brook, & James E. Smeeding. (2004). RETROSPECTIVE COST ANALYSES OF SWITCHING FROM A TWICE-DAILY PROTON PUMP INHIBITOR TO ONCE-DAILY ESOMEPRAZOLE. The American Journal of Gastroenterology. 99. S232–S232. 1 indexed citations

19.

Howard, Richard T., James P. Wilson, & James E. Smeeding. (2000). Therapeutic Interchange of H₂ Antagonists: Cost Savings and Impact on Outcomes. Hospital Pharmacy. 35(4). 387–393. 2 indexed citations

20.

Khan, Zeba M., Karen L. Rascati, Jim M. Koeller, & James E. Smeeding. (1999). Fax technology for collecting outcomes data in a computer database. American Journal of Health-System Pharmacy. 56(24). 2540–2542. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact